Thus, to investigate the mechanisms of resistance to BYL719, we selected the BYL719-sensitive luminal human breast cancer cell lines T47D and MCF7 harboring the H1047R and E545K PIK3CA hotspot mutations, respectively. This evidence concerns the gene PIK3CA and breast cancer.